Amgen vs Structure Therapeutics: Revenue Comparison
Amgen (AMGN) and Structure Therapeutics (GPCR) are peers in GLP-1. Amgen reported revenue of $8.6B as of Q1 2026, compared with $0 for Structure Therapeutics. Amgen leads on revenue.
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Amgen 8.618, Structure Therapeutics 0.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Amgen, Structure Therapeutics.| Metric | Amgen | Structure Therapeutics |
|---|---|---|
| Market Cap | - | - |
| Revenue | $8.62B | $0 |
| Cost of Revenue | $2.74B | $1.00M |
| Gross Profit | $5.87B | $-1.00M |
| Operating Income | $2.67B | $-90.00M |
| Net Income | $1.82B | $-76.00M |
| R&D Expense | $1.72B | $67.00M |
| Earnings Per Share | $3.34 | -$1.05 |
| Gross Margin | 68.2% | - |
| Operating Margin | 30.9% | - |
| Net Profit Margin | 21.1% | - |
| Free Cash Flow | $1.48B | $14.00M |
| Cumulative Free Cash Flow | $165.69B | $-469.00M |
| Operating Cash Flow | $2.19B | $15.00M |
| Cash & Equivalents | $12.04B | $316.00M |